Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B

Journal of medical virology

Volumn 86, Issue 10, 2014, Pages 1705-1713

  Chen, Xuefu ^a   Chen, Xiaoping ^a   Chen, Wenli ^a   Ma, Xiaojun ^a   Huang, Jing ^a   Chen, Ren ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

chronic hepatitis B; HBeAg; HBsAg clearance rate; HBV DNA; PEG IFN 2a

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; VIRUS DNA;

ADOLESCENT; ADULT; BLOOD; CHINA; CONTROLLED STUDY; DRUG THERAPY; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; VIRUS LOAD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHINA; DNA, VIRAL; DRUG THERAPY; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; YOUNG ADULT;

EID: 84926079007     PISSN: None     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24013     Document Type: Article

References (0)